5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | N/A | N/A | N/A | 10,840.40▼ | 10,422.60▲ |
MA10 | N/A | N/A | N/A | 10,659.60▲ | 10,423.70▲ |
MA20 | N/A | N/A | N/A | 10,308.20▲ | 10,153.75▲ |
MA50 | N/A | N/A | N/A | 10,365.30▲ | 9,212.00▲ |
MA100 | N/A | N/A | N/A | 9,930.40▲ | 8,554.87▲ |
MA200 | N/A | N/A | N/A | 9,295.30▲ | 7,729.51▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | 79.130▲ | -0.425▼ |
RSI | N/A | N/A | N/A | 61.114▲ | 62.725▲ |
STOCH | N/A | N/A | N/A | 85.877▲ | 60.956 |
WILL %R | N/A | N/A | N/A | -17.571▲ | -14.864▲ |
CCI | N/A | N/A | N/A | 73.356 | 122.231▲ |
Tuesday, July 05, 2022 03:27 AM
AstraZeneca (NASDAQ: AZN) has announced that it plans to acquire U.S. oncology firm TeneoTwo in a deal worth up to $1.27B, as the British-base ...
|
Tuesday, July 05, 2022 01:12 AM
AstraZeneca today announced an agreement to acquire TeneoTwo, Inc. (TeneoTwo)i, including its Phase I clinical-stage CD19/CD3 T-cell engager, TNB-486, currently under evaluation in relapsed and ...
|
Monday, July 04, 2022 11:25 PM
By redirecting the body's natural immune response to target B-cell malignancies, the TNB-486 drug being developed by TeneoTwo could be ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
04/07/22 | 10,808.00 | 10,898.00 | 10,770.00 | 10,808.00 | 863,389 |
01/07/22 | 10,722.00 | 10,782.00 | 10,568.00 | 10,754.00 | 2,073,571 |
30/06/22 | 10,842.00 | 10,946.00 | 10,678.00 | 10,800.00 | 2,421,105 |
29/06/22 | 10,752.00 | 11,054.00 | 10,736.00 | 11,054.00 | 1,610,648 |
28/06/22 | 10,760.00 | 10,844.00 | 10,744.00 | 10,786.00 | 1,522,146 |
27/06/22 | 10,714.00 | 10,850.00 | 10,652.00 | 10,806.00 | 1,698,548 |
24/06/22 | 10,464.00 | 10,792.00 | 10,422.00 | 10,776.00 | 2,198,967 |
23/06/22 | 10,246.00 | 10,404.00 | 10,158.00 | 10,380.00 | 1,419,592 |
22/06/22 | 10,100.00 | 10,320.00 | 10,050.00 | 10,304.00 | 1,710,668 |
21/06/22 | 10,032.00 | 10,146.00 | 10,006.00 | 10,128.00 | 1,727,754 |
|
|
||||
|
|
||||
|
|